{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:43:33Z","timestamp":1777934613311,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diagnoses of myeloproliferative disorder is based on molecular marker. Chronic Myeloid Leukemia and Myeloproliferative neoplasms were considered mutually exclusive and co-existence of BCR\/ABL1 and JAK2 mutation is a rare phenomenon.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>Here, we present two cases of co-existence of BCR-ABL and JAK2V617F positivity. We characterize the course of the disease, mainly the minimal residual disease. Management and outcome: The two cases was initially managed as Chronic Myeloid Leukemia and treated by TKI inhibitors. The first one was diagnosed in 2010. He started the first line of TKI, and then switched to second line without obtaining a major molecular response. Hence he was tested for JAK2V617F mutation and positivity was diagnosed. The second patient showed Chronic Myeloid Leukemia phenotype with coexistence of BCR\/ABL1 and JAK2 mutation at diagnosis. Molecular monitoring reveals a high BCR-ABL1 transcript level (20%) at the last follow-up (12\u2009months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Ours results highlight that JAK2V617F\/BCR-ABL double positivity may be a potential marker of resistance in Chronic Myeloid Leukemia and clonal molecular analysis is mandatory to elucidate the mechanism. Moreover, the combination of JAK and TKI inhibitors might be effective and potentially be guided by molecular monitoring of minimal residual disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1078155221991646","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T06:36:22Z","timestamp":1613198182000},"page":"1784-1789","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Co-existence of\n                    <i>BCR-ABL<\/i>\n                    and\n                    <i>JAK2V617F<\/i>\n                    mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?"],"prefix":"10.1177","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4415-8785","authenticated-orcid":false,"given":"Rim","family":"Frikha","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, University Hospital of Sfax, Sfax, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Turki","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University Hospital of Sfax, Sfax, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfa","family":"Kassar","sequence":"additional","affiliation":[{"name":"Department of Haematology, University Hospital of Sfax, Sfax, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moez","family":"Elloumi","sequence":"additional","affiliation":[{"name":"Department of Haematology, University Hospital of Sfax, Sfax, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassen","family":"Kamoun","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University Hospital of Sfax, Sfax, Tunisia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"bibr1-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0054-y"},{"key":"bibr2-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2008.12.010"},{"key":"bibr3-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70206-1"},{"key":"bibr4-1078155221991646","first-page":"472","volume":"21","author":"Pahore ZA","year":"2011","journal-title":"J Coll Physicians Surg Pak"},{"key":"bibr5-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.06.011"},{"key":"bibr6-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12798"},{"key":"bibr7-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-017-0781-4"},{"key":"bibr8-1078155221991646","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4631"},{"key":"bibr9-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1186\/2162-3619-2-24"},{"key":"bibr10-1078155221991646","doi-asserted-by":"publisher","DOI":"10.4103\/0300-1652.149177"},{"key":"bibr11-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-061135"},{"key":"bibr12-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-013-1480-z"},{"key":"bibr13-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2018.1498182"},{"key":"bibr14-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-3165-9"},{"key":"bibr15-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13932"},{"key":"bibr16-1078155221991646","doi-asserted-by":"publisher","DOI":"10.5858\/2007-131-1719-TOPVTC"},{"key":"bibr17-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404591"},{"key":"bibr18-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404730"},{"key":"bibr19-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405088"},{"key":"bibr20-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2087"},{"key":"bibr21-1078155221991646","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2013.33.3.229"},{"key":"bibr22-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-013-1326-8"},{"key":"bibr23-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0131-2"},{"key":"bibr24-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01063.x"},{"key":"bibr25-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.10.018"},{"key":"bibr26-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3402-x"},{"key":"bibr27-1078155221991646","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.102"},{"key":"bibr28-1078155221991646","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0609.2010.01458.x","volume":"85","author":"Tefferi A","year":"2010","journal-title":"Eur J Haematol"},{"key":"bibr29-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404993"},{"key":"bibr30-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.09.025"},{"key":"bibr31-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.08.009"},{"key":"bibr32-1078155221991646","doi-asserted-by":"crossref","DOI":"10.1186\/2162-3619-2-24","volume":"2","author":"Pastore F","year":"2013","journal-title":"Exp Hematol Oncol"},{"key":"bibr33-1078155221991646","first-page":"738428","volume":"2014","author":"Maerki J","year":"2014","journal-title":"Case Rep Hematol"},{"key":"bibr34-1078155221991646","doi-asserted-by":"publisher","DOI":"10.1177\/2324709619832322"},{"key":"bibr35-1078155221991646","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i9.1087"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155221991646","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155221991646","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155221991646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:26:10Z","timestamp":1777688770000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155221991646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1177\/1078155221991646"],"URL":"https:\/\/doi.org\/10.1177\/1078155221991646","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]}}}